Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Cardiovascular Medicine, Omihachiman Community Medical Center, Shiga, Japan.
PLoS One. 2023 Jan 27;18(1):e0280683. doi: 10.1371/journal.pone.0280683. eCollection 2023.
Balloon pulmonary angioplasty (BPA) is used for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and residual pulmonary hypertension after pulmonary endarterectomy (PEA) to improve hemodynamics, right ventricular function, and exercise capacity. However, the effectiveness and safety of guide extension catheters for BPA treatment in patients with CTEPH have not been demonstrated.
We retrospectively analyzed 91 lesions in 55 sessions of 28 patients with CTEPH who underwent BPA using a guide extension catheter. The purpose (backup, coaxial, and extension), efficacy, and safety of the guide extension catheters were explored. The efficacy of the guide extension catheter was assessed based on the success of the procedures and safety was evaluated based on procedure-related complications.
Regarding the intended use, a guide extension catheter was used to strengthen the backup force of the guiding catheter in 52% of cases, extend the tip of the catheter in 38% of cases, and maintain the coaxiality of the guiding catheter in 10% of cases. Procedural success was achieved in 92.7% of 55 sessions and in 95.6% of 91 lesions. Complex lesions had a lower success rate than simple lesions (p = 0.04). Regarding safety concerns, complications were observed in 5 of 55 sessions (9.1%) and 6 of 91 lesions (6.6%). Only one case of pulmonary artery dissection using a guide extension catheter was reported. Except for this one case, extension catheter-related complications were not observed.
A guide extension catheter can be used safely in BPA procedures with anatomically complex pulmonary artery branches and complex lesions by increasing backup support.
球囊肺动脉成形术(BPA)用于治疗无法手术的慢性血栓栓塞性肺动脉高压(CTEPH)和肺动脉内膜切除术(PEA)后的残余肺动脉高压,以改善血液动力学、右心室功能和运动能力。然而,在 CTEPH 患者中使用导引导管延长导管进行 BPA 的有效性和安全性尚未得到证实。
我们回顾性分析了 28 例 CTEPH 患者 55 次 BPA 中使用导引导管延长导管的 91 处病变。探讨了导引导管延长导管的目的(后备、同轴和延长)、疗效和安全性。根据手术的成功程度评估导引导管延长导管的疗效,根据与手术相关的并发症评估安全性。
关于预期用途,在 52%的病例中,导引导管延长导管用于增强导引导管的后备力,在 38%的病例中用于延长导管尖端,在 10%的病例中用于保持导引导管的同轴性。55 次手术中有 92.7%(51 次)成功,91 处病变中有 95.6%(87 处)成功。复杂病变的成功率低于简单病变(p=0.04)。关于安全问题,在 55 次手术中有 5 次(9.1%)和 91 处病变中有 6 次(6.6%)出现并发症。仅报告了 1 例使用导引导管延长导管导致的肺动脉夹层。除了这一个病例,没有观察到与延长导管相关的并发症。
通过增加后备支持,导引导管延长导管可安全用于解剖结构复杂的肺动脉分支和复杂病变的 BPA 手术。